Utah Addiction Center Offers Physician Training

Utah Addiction Center Offers Physician Training

Aug 29, 2004 6:00 PM

The Utah Addiction Center at the University of Utah will offer a training session Oct. 16 to help physicians treat patients addicted to opioids--drugs commonly given for pain relief--with a new medication called Buprenorphine.

The training, open to physicians and their staff, takes place from 8 a.m.-5:30 p.m. at the Alta Club, 100 East South Temple, in Salt Lake City. The program is part of a national training initiative of the American Society of Addiction Medication (ASAM), according to Barbara Hardy, Ph.D., co-director of the Utah Addiction Center.

A dinner and lecture open to the public will follow the training course at 6:30 p.m.

"Opioid addiction through prescription abuse, particularly among young people, is becoming a major health issue in the United States," Hardy said. "Physicians often are best positioned to identify and treat patients addicted to these drugs."

Opioids include drugs such as OxyContin and Lortab and are given for post-operative pain management. They also are prescribed for chronic pain, such as arthritis.

Buprenorphine received U.S. Food and Drug Administration approval for treating heroin and opioid addiction in October 2002. It is related to morphine, but does not cause the same high, dependence, or withdrawal syndrome. Other drugs to treat heroin and opioid addiction, such as methadone, will continue to be used as well.

Cost for the training is $150 for ASAM members and $175 for non-members who register by September 14. The fee for participants who register by Oct. 8 will be $180 for ASAM members and $210 for non-members. On-site registration costs $250.

Program faculty include Hardy, Glen R. Hanson, D.D.S., Ph.D., Utah Addiction Center director and professor of pharmacology and toxicology at the U of U College of Pharmacy, faculty from the College of Pharmacy and the U School of Medicine's Department of Psychiatry, and other physicians.

The training counts for up to nine Category One continuing medical education credits toward the American Medical Association's Physicians' Recognition Award. Physicians who complete the training also will be eligible to request a waiver from the Federal Substance Abuse and Mental Health Services Administration to prescribe Buprenorphine in their treatment of opioid-addicted patients. Physicians must be certified by ASAM and receive eight hours of training to prescribe Buprenorphine.

Hardy encourages any physician interested in treating opioid addiction to take the training. But physicians and their staff who work in primary care, psychiatry, HIV/AIDS treatment, pain management, oncology, and rehabilitation also are especially encouraged to attend.

Following the training course, Kevin T. McCauley, M.D., director of medical education, Sober Living By the Sea Treatment Centers, Newport Beach, Calif., will speak about his journey through Demerol and cocaine addiction. The dinner and lecture cost $20.

For registration information contact Tia Korologos of ESI Management Group at (801) 272-9446 or at tia_esimgt@msn.com.

# # #

Visit our News Archive for a complete list of previous News.